Lenvatinib

Lenvatinib

Lenvatinib

Min.Order / FOB Price:Get Latest Price

100 Gram

Negotiable

  • Min.Order :100 Gram
  • Purity: 99%
  • Payment Terms : L/C,T/T

Keywords

Lenvatinib E7080 (Lenvatinib) Lenvatinib (E7080)

Quick Details

  • Appearance:white to off-white powder
  • Application:treatment for differentiated thyroid carcinoma
  • PackAge:aluminum foil bag or 25kg drum
  • ProductionCapacity:1|Kilogram|Month
  • Storage:below 25 degree, sealed container
  • Transportation:below 25 degree, sealed container

Superiority:

Established in 2011, Shandong Green Bio-Pharmaceutical Co., Ltd. specializes in R&D, producing and selling APIs and intermediates. It is located in the Heze High-tech Development Zone, Shandong Province, covers more than 80,000 square meters.

We have pre-production and large production lines with a research center, which makes us have quite strong R & D and supply capabilities, including lines of Sodium Bisulfite with 50000 tons per year, Anhydrous Sodium Sulfite with 10000 tons per year, Cyclopentanone with 600 tons, 2-Methylindoline with 50 tons per year and so on.

Details:

Product name: Lenvatinib

Synonyms: 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080;E7080 (Lenvatinib);Lenvatinib (E7080);ER-203492-00;1-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide XEN445;E70801-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea

CAS No.: 417716-92-8

Molecular formula: C21H19ClN4O4

Molecular weight: 426.85

Application: treatment for differentiated thyroid carcinoma

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View